2020
DOI: 10.1016/j.nrl.2018.07.001
|View full text |Cite
|
Sign up to set email alerts
|

Utilidad del exoma en el estudio de la paraparesia espástica y la atrofia cerebelosa: mutación de novo en el gen KIF1A, una nueva esperanza pronóstica

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2020
2020
2021
2021

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 13 publications
0
2
0
Order By: Relevance
“…Furthermore, urological abnormalities other than incontinence are observed across three patients: neurogenic bladder/bowel, double collecting system, and hydronephrosis of unspecified etiology, which can be caused by neurogenic bladder or double collecting system. While neurogenic bladder has been previously reported (Okamoto et al, 2014;Urtiaga Valle et al, 2020), a double collecting system is a novel phenotype. However, without resolving whether the hydronephrosis of unspecified etiology is caused by a double collecting system, we cannot rule out a double collecting system as an incidental finding.…”
Section: Discussionmentioning
confidence: 90%
“…Furthermore, urological abnormalities other than incontinence are observed across three patients: neurogenic bladder/bowel, double collecting system, and hydronephrosis of unspecified etiology, which can be caused by neurogenic bladder or double collecting system. While neurogenic bladder has been previously reported (Okamoto et al, 2014;Urtiaga Valle et al, 2020), a double collecting system is a novel phenotype. However, without resolving whether the hydronephrosis of unspecified etiology is caused by a double collecting system, we cannot rule out a double collecting system as an incidental finding.…”
Section: Discussionmentioning
confidence: 90%
“…Our 4 sporadic cases may add to this variability. mutations acquired de novo [6,9,11,24,[26][27][28][29][30][31][32][33] several groups of sporadic cases were reported: 4 Dutch patients [25], 6 patients age 1.5-16 years from USA [7], 5 cases among 62 unrelated patients with cerebral atrophy of unestablished nature [9]. In addition, one of the first cohorts with de novo mutations in KIF1A was a representative international group (Canada, USA, Netherlands and Finland): 14 patients (monozygotic twin pair among them) age 2.5-24 years, all had de novo mutations in KIF1A [8].…”
Section: Discussionmentioning
confidence: 99%